MiMedx Group, Inc. (NASDAQ:MDXG - Get Free Report) gapped up before the market opened on Thursday . The stock had previously closed at $7.47, but opened at $7.99. MiMedx Group shares last traded at $7.94, with a volume of 490,578 shares trading hands.
Analyst Upgrades and Downgrades
A number of equities analysts have weighed in on the company. StockNews.com lowered MiMedx Group from a "strong-buy" rating to a "buy" rating in a research note on Friday, November 8th. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $11.00 target price on shares of MiMedx Group in a report on Thursday, August 1st. Finally, Craig Hallum reduced their price objective on MiMedx Group from $14.00 to $12.00 and set a "buy" rating on the stock in a research report on Thursday, August 1st. Six investment analysts have rated the stock with a buy rating, According to MarketBeat, the stock presently has an average rating of "Buy" and an average price target of $12.00.
Get Our Latest Report on MiMedx Group
MiMedx Group Stock Performance
The company has a market capitalization of $1.36 billion, a PE ratio of 16.33 and a beta of 1.94. The stock's fifty day simple moving average is $6.18 and its 200-day simple moving average is $6.73. The company has a debt-to-equity ratio of 0.10, a quick ratio of 3.53 and a current ratio of 4.10.
Institutional Trading of MiMedx Group
A number of hedge funds and other institutional investors have recently modified their holdings of the business. ProShare Advisors LLC lifted its holdings in MiMedx Group by 8.5% in the first quarter. ProShare Advisors LLC now owns 20,735 shares of the company's stock worth $160,000 after acquiring an additional 1,631 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its stake in MiMedx Group by 1.0% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 183,021 shares of the company's stock valued at $1,082,000 after purchasing an additional 1,822 shares in the last quarter. Hsbc Holdings PLC raised its position in MiMedx Group by 7.3% in the second quarter. Hsbc Holdings PLC now owns 34,343 shares of the company's stock worth $233,000 after acquiring an additional 2,329 shares in the last quarter. The Manufacturers Life Insurance Company lifted its stake in MiMedx Group by 7.6% during the second quarter. The Manufacturers Life Insurance Company now owns 45,623 shares of the company's stock valued at $316,000 after purchasing an additional 3,222 shares during the last quarter. Finally, Marshall Wace LLP boosted its stake in shares of MiMedx Group by 1.1% during the 2nd quarter. Marshall Wace LLP now owns 298,818 shares of the company's stock worth $2,071,000 after acquiring an additional 3,223 shares in the last quarter. 79.15% of the stock is owned by hedge funds and other institutional investors.
MiMedx Group Company Profile
(
Get Free Report)
MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins.
Further Reading
Before you consider MiMedx Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MiMedx Group wasn't on the list.
While MiMedx Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
